Brian Teter Email & Phone Number

Costa Mesa, Ca, Us

Cambridge, Ma, Us

Responsible for identifying and maintaining business relationships with key academic and GPO community accounts in the Western US. Key accounts include City of Hope, University of California, Cedars Sinai, Kaiser Permanente, Scripps Health, Banner MD Anderson, Fred Hutch, The Oncology Institute, Sutter Health. Oral Oncology portfolio covers mCRC, NSCLC, MM, CML, AMLCore Responsibilities:• Develop and execute account level business plans for targeted GPO member accounts based on Takeda’s commercial goals. Identification of contacts and understand key GPO stakeholders representing a broad range of functions and management levels, both internal and external• Lead activities of cross-functional partners within targeted accounts. Provide guidance and assistance relative to company-wide and franchise-specific opportunities within targeted and assigned regional/national oncology accounts• Leverage appropriate proactive methods to gather and demonstrate a thorough understanding of integrated customer accounts, customer business models, financial dynamics, marketplace developments and trends, and Takeda strategies and processes.• Assess key assigned regional and national oncology GPO clients. Identify new customers or organizations with the potential to impact Takeda business• Through effective strategic engagement with specified customers, position Takeda Oncology as a preferred partner for current and future portfolio initiatives• Work with internal matrix partners to deliver on company initiatives and priorities• Identify key business leaders and builds and maintains long-term relationships with healthcare population-based decision makers• Identify ways to streamline engagements, identify opportunities and maximize resources with strategic accounts• Build credibility through an in-depth understanding of an accounts business, organization, external environment, and industry• Identify potential collaboration projects around HEOR, RWE, SDOH

North Chicago, Illinois, Us

Integral role in engaging external lymphoma experts for the launch of Epkinly, a novel first in class subcutaneous bispecific antibody indicated for 3L+ Diffuse Large B-Cell patients. Key accounts covered in CA, OR, WA, AK, ID, UT, NV, CO, NE, IAResponsibilities:· Develop, implement and maintain accountability for interactions and feedback with national and regional oncology hematology external experts· Ensure external expert perspectives are shared and considered consistently across leadership and the Integrated Brand Teams· Manage planning and execution of marketing consultancy arrangements· Engage in congress related engagement activities nationally, including supporting and executing any ongoing Thought Leader strategies and tactics· Development and execution of national and regional advisory boards in collaboration with brand teams· Continually identify and develop Thought Leaders, to consistently build our Thought Leaders base for the franchise and the brands· Partner with commercial team, agencies, legal, compliance, medical and co-marketing partners to successfully drive the business forwardLeadership:· Team Congress Lead-2023· Team Speakers Bureau Lead- 2023· Follicular Lymphoma Brand Lead- 2023

Sunnyvale, Ca, Us

Responsible for managing several key oncology accounts on the West Coast US: National Cancer Institutions (NCI), large Medically Integrated Dispensing (MID)/In-Office Dispensing (IOD) practices, large health systems, integrated delivery networks (IDNs), Regional Payers, and State Medicaid programs. Key accounts include: City of Hope, UC Health System, Cedars Sinai, Sutter Health, Stanford Health, Oregon Health and Science University, Swedish Cancer Institute, Fred Hutchinson Cancer Center, Providence HealthTarget account activity:• Work with key decision makers at IDNs, Regional Payers, and State Medicaid programs to ensure appropriate coverage and access for approved product indications• Share clinical and economic value propositions, HEOR data to build strategic relationships with key stakeholders which include Pharmacy and Medical Directors, P&T, Pathway Committees, C-Suite, Health Outcomes and Informatics, Industry Relations and Contracting, Finance, etc.• Explore clinical pathway opportunities• Manage development and awareness of contracting initiatives• Analyze market trends, payer policies, and sales data to create strategic plans to support access and explore new business opportunities• Manage Regional Oncology State Societies• Educate and provide updates to State Societies regarding label updates and program changesCross-functional partnering and communication:• Coordinate with Sales and Medical Affairs teams to support appropriate Account Management activities• Develop regional analyses outlining payer trends, market trends, distribution model trends, and other ad-hoc analyses to support Market Access, Sales, and Commercial leadership• Educate and inform sales teams on Market Access initiatives and approved marketing messages• Present Market Access initiatives at Regional/National sales meetings and on Division calls• Work cross-functionally with other departments, such as Trade and Business Analytics

North Chicago, Illinois, Us

Responsible for Imbruvica access and reimbursement support in the Northern California, Nevada, Colorado, Utah, Idaho, and Wyoming hematology markets.Responsibilities• Provide expertise on coverage and common access and reimbursement challenges affecting Imbruvica• Educate key accounts on payer processes and procedures• Advise HCPs on patient prescription status and program eligibility• Collaborate with Field Sales, National Accounts, and Trade teams to resolve access issues• Report back payer trends related to Imbruvica to Patient Services and Market Access account management teamsAchievements• Team AXCESS Coin Award for Leadership-2021

Sunnyvale, Ca, Us

Territory covers Orange County/ Los Angeles academic institutions which include UCI, UCLA, USC, Cedars SinaiResponsible for successful promotion of Imbruvica (ibrutinib), an oral Bruton's tyrosine kinase (BTK) inhibitor indicated for rare leukemias/lymphomas- CLL/SLL, Marginal Zone Lymphoma, Mantle Cell Lymphoma, Waldenstrom's Macroglobulinemia, and Chronic Graft vs Host DiseaseAchievements• Promoted to Senior Hematology Clinical Account Specialist- 2020• 2018 Pulse of the Division Award Recipient-2019• Finished 2018 ranked #18 out of 54• Finished at 101% PTP-2019• Received “Exceeded Expectations” rating for 2018 Annual Review-2019• Ranked #3 in the Region and #7 Nationally- Q4 2018• Ranked #1 in the Region and #6 Nationally- Q2 2018• Finished 2017 ranked #11 out of 43• Ranked #7 out of 43 for H2 2017 Sales Contest • Finished at 101% PTP-2017• Finished Q2 ranked #6 in the Region-2017Leadership• One of three candidates selected nationally to the Market Access Preceptorship Program- 2019• Selected to Insights to Action National Advisory Board- 2019• Accepted into Market Access Mentorship Program- 2018• Assist with new candidate selection and training of new hires• Selected as analytics lead for Southwest District

Managed seven representatives on the West Coast promoting Zubsolv- a buprenorphine/naloxone formulation indicated for the maintenance treatment of opioid dependence. Team responsible for driving sales, identifying Key Opinion Leaders, and being a resource for certified addiction professionals. Call points include certified addiction professionals and psychiatrists in Intensive Outpatient Facilities, Detoxification and Rehabilitation Facilities, Opioid Treatment Facilities, Inpatient Hospital Facilities

Stamford, Ct, Us

DISTRICT MANAGER 10/10-PresentAchievements Received 4 out of 5 Rating- Highly Effective Manager Annual Review- 2012,2013 Regional Manager of the Year Runner Up-2012 District Manager’s President’s Council Runner Up-2012 District Ranked #8 out of 64 Nationally-2012 Regional District Manager of the Year-2011 Top 10% Topper’s Club Award-2011 Topper’s DM Club Trip Recipient-2011 Topper’s DM Club Inspection Trip Recipient-2011 District Ranked #3 out of 64 Nationally-2011 Ranked #2 out of 64 in the Nation for Butrans Prescription per Rep-2011Leadership Coached and Developed Butrans National Sales Leader - 2015 Coached and Developed Regional Sales Representative of the Year- 2014 Developed and promoted Sales Rep to Training Manager- Training Department-2014 Appointed to District Manager’s Advisory Council- Southwest Region-2013,2014 Hired and developed National Sales Rep of the Year-2012 Developed and promoted Sales Rep to Product Manager- Marketing Department-2012 Sales Representative promoted to Medical Marketing Representative-2012 Sales Representative promoted to Regional Field Trainer-2011/2012 Sales Representative completed Management Development Program-2012 Hired and developed National Sales Rep of the Year Runner Up-2011 Three Reps ranked in Top 10% of National Sales -2011 Two new hires finished in Top 10% of National Sales-2011

Stamford, Ct, Us

MEDICAL MARKETING REPRESENTATIVE/ DISTRICT FIELD TRAINER 02/06- 10/10Achievements President’s Council Award Recipient-2010 Top 10% Topper’s Club Winner-2010 Ranked #1 in District, #8 in Region, #39 in Nation for Sales- 2nd Qtr 2010 Ranked #3 in Nation for 2nd period of 2009/2010 Topper’s Club Contest Ranked # 40 out 400 for 2009/2010 Topper’s Club Contest Completed REMAP /PCi Assessment Center- Management Development Program-2009 Top 10% Topper’s Club Winner-2008 Ranked # 9 out of 400 in the company for Topper’s Club Contest-2008 Consistently ranked in top 3 for District sales-2006-2010Leadership District Field Trainer for San Diego District-2008-2010

Promoted cardiovascular therapies Sular, Triglide, Altoprev, Nitrolingual Pumpspray and diabetes therapy Fortamet to Cardiologists, Nephrologists, Endocrinologist and General PractitionersAchieved 100% of quota for Cardiovascular products- 2005-2006Promoted to District Field Trainer-2006